In short, though antioxidants have emonstrated some possibility in the treatment of periodontitis, their clinical application still has some challenges
Graf WD, Marin-Garcia J, Gao HG, Pizzo S, Naviaux RK, Markusic D, et al
April 1, 2025: MDL Against Ozempic and Other GLP-1s Top 1,600 in April As of April 1, 2025, there are 1,685 active lawsuits pending against Novo Nordisk and other pharmaceutical companies that sold GLP-1 drugs like Ozempic
It should be noted, however, that only the short/medium-term effects of GSH supplementation were evaluated during this trial
A 2021 retrospective observational study cited in the PMC literature directly compared BPC-157 alone versus BPC-157 combined with TB-500 in a knee injection protocol and found the combination to be associated with improved outcomes providing the first head-to-head comparative observation of the two compounds used together versus independently